A Phase 3 interventional study of fluconazole in Tinea Capitis, sponsored by Pfizer. Completed at 31 sites in 2 countries. Open to participants aged 3 Years to 12 Years. Per ClinicalTrials.gov, last updated 2021-07-16.
Sponsored by Pfizer · Phase 3, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The purpose of this study is to evaluate the safety and efficacy of fluconazole for the treatment of tinea capitis in pediatric patients aged 3 to 12 years.
Pfizer is the lead sponsor of 3,337 studies on the registry; 150 are open to participants now.
Of its 601 completed or terminated interventional studies of FDA-regulated products, 392 (65%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Drug: fluconazole
Fluconazole oral suspension 6 mg/kg/day for 6 weeks followed by 4 weeks without treatment
Combined clinical and mycological outcome at Week 6
Time frame: Week 6
Clinical outcome based on signs and symptoms at Weeks 3, 6, and 10
Time frame: Weeks 3, 6, and 10
Combined clinical and mycological outcome at Weeks 3 and 10
Time frame: Weeks 3 and 10
Mycological outcome based on culture results at Weeks 3, 6, and 10
Time frame: Weeks 3, 6, and 10
Culture results at Weeks 3, 6, and 10
Time frame: Weeks 3, 6, and 10
The record gives a start of Nov 2002 and a completion of Mar 2003. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jul 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Fluconazole
Tinea Capitis